VBIO (Valion Bio) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VBIO Valion Bio Inc VBIO
23 GF Score
Price $0.32
! 1 Warning Sign
View Full Analysis

What is Valion Bio Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

VBIO
23GF Score
Valion Bio Inc VBIO
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valion Bio Business Description

Address 1305 East Houston Street, Suite 311, Building 1, San Antonio, TX, USA, 78205
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
23GF Score

Get the complete analysis for VBIO

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.32
Price